225 related articles for article (PubMed ID: 22207628)
1. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells.
Feldman DE; Chen C; Punj V; Tsukamoto H; Machida K
Proc Natl Acad Sci U S A; 2012 Jan; 109(3):829-34. PubMed ID: 22207628
[TBL] [Abstract][Full Text] [Related]
2. High expression of leptin receptor leads to temozolomide resistance with exhibiting stem/progenitor cell features in gliobalastoma.
Han G; Wang L; Zhao W; Yue Z; Zhao R; Li Y; Zhou X; Hu X; Liu J
Cell Cycle; 2013 Dec; 12(24):3833-40. PubMed ID: 24131927
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
4. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
5. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.
Zheng Q; Dunlap SM; Zhu J; Downs-Kelly E; Rich J; Hursting SD; Berger NA; Reizes O
Endocr Relat Cancer; 2011 Aug; 18(4):491-503. PubMed ID: 21636700
[TBL] [Abstract][Full Text] [Related]
6. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
7. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.
Kashyap V; Rezende NC; Scotland KB; Shaffer SM; Persson JL; Gudas LJ; Mongan NP
Stem Cells Dev; 2009 Sep; 18(7):1093-108. PubMed ID: 19480567
[TBL] [Abstract][Full Text] [Related]
8. Leptin enhances the invasive ability of glioma stem-like cells depending on leptin receptor expression.
Han G; Zhao W; Wang L; Yue Z; Zhao R; Li Y; Zhou X; Hu X; Liu J
Brain Res; 2014 Jan; 1543():1-8. PubMed ID: 24161825
[TBL] [Abstract][Full Text] [Related]
9. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
Seo S; Jeon HY; Kim H
DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
12. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells.
Zheng Q; Banaszak L; Fracci S; Basali D; Dunlap SM; Hursting SD; Rich JN; Hjlemeland AB; Vasanji A; Berger NA; Lathia JD; Reizes O
Endocr Relat Cancer; 2013 Dec; 20(6):797-808. PubMed ID: 24025407
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network.
Jang H; Kim TW; Yoon S; Choi SY; Kang TW; Kim SY; Kwon YW; Cho EJ; Youn HD
Cell Stem Cell; 2012 Jul; 11(1):62-74. PubMed ID: 22608532
[TBL] [Abstract][Full Text] [Related]
14. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
15. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
17. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency.
Tapia N; MacCarthy C; Esch D; Gabriele Marthaler A; Tiemann U; Araúzo-Bravo MJ; Jauch R; Cojocaru V; Schöler HR
Sci Rep; 2015 Aug; 5():13533. PubMed ID: 26314899
[TBL] [Abstract][Full Text] [Related]
20. Membrane potential differences and GABAA receptor expression in hepatic tumor and non-tumor stem cells.
Bautista W; Perez-Alvarez V; Burczynski F; Raouf A; Klonisch T; Minuk G
Can J Physiol Pharmacol; 2014 Jan; 92(1):85-91. PubMed ID: 24383877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
